Search For "shalini"
AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials f
Updated : 4 years, 12 months ago IST
New Delhi [India], June 14 (ANI): The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.
Read More
People must follow appropriate behaviour as Covid-19 has not yet been erad
Updated : 4 years, 12 months ago IST
New Delhi [India], June 13 (ANI): With parts of the country slowly opening up as Covid-19 cases drop, experts have cautioned that the coronavirus has not yet been eradicated and that the onus lies on people now to ensure that Covid hotspots are not created in their areas.
Read More
Serosurvey will help to know how far we are from herd immunity, says scien
Updated : 4 years, 12 months ago IST
New Delhi [India], June 12 (ANI): With the Indian Council of Medical Research slated to conduct the fourth national serosurvey in the country this month, a scientist associated with CSIR has said it will help find out "how far are we from herd immunity" against COVID-19.
Read More
Bharat Biotech to undertake clinical trials in US
Updated : 4 years, 12 months ago IST
New Delhi [India], June 12 (ANI): India's first indigenous COVID-19 vaccine manufacturer Bharat Biotech on Saturday said that it will be carrying out clinical trials in the US to support the marketing application for Covaxin in the country.
Read More
No changes as of now in gap between Covishield doses, say govt sources
Updated : 4 years, 12 months ago IST
New Delhi [India], June 12 (ANI): Amid calls to reduce the gap between two doses of Serum Institute of India's COVID-19 vaccine Covishield based on the new findings by Public Health England, the Central government will not take the decision to change the dosage interval immediately, said
Read More
Vaccines are working against infection, severe disease of COVID-19, reveal
Updated : 4 years, 12 months ago IST
New Delhi [India], June 11 (ANI): Christian Medical College, Vellore, a 2,600 bed tertiary care hospital in India with 10,600 employees has vaccinated 84.8 per cent staff with majority of them getting Covishield and rest received Covaxin by Bharat Biotech, a latest research done on health
Read More
No need to vaccinate people who had documented COVID-19 infection, suggest
Updated : 4 years, 12 months ago IST
New Delhi [India], June 11 (ANI): A group of public health experts, including doctors from AIIMS and members from the national task force on COVID-19, has recommended that there is no need to vaccinate people who had documented COVID-19 infection and underlined that mass, indiscriminate,
Read More
'Delta' COVID-19 variant found to be predominant despite complete, partial
Updated : 5 years ago IST
New Delhi [India], June 10 (ANI): A preliminary study conducted by the All India Institute of Medical Science (AIIMS) Delhi claimed that the presence of COVID-19 Delta variant (B1.617.2) is predominantly found even after getting a single dose or both doses of COVID-19 vaccine.
Read More
Covishield produced more antibodies than Covaxin, says preliminary study
Updated : 5 years ago IST
New Delhi [India], June 7 (ANI): Covishield vaccine produced more antibodies than Covaxin, according to a preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) involving healthcare workers (HCW) who have received both doses of either of the two vaccines.
Read More
Maintain safe number of ICU beds, harmonise units of health system to face
Updated : 5 years ago IST
New Delhi [India], June 6 (ANI): Dr Naveet Wig, chairman of AIIMS COVID Taskforce, on Sunday stressed on maintaining a safe number of ICU beds and harmonising different units of the health system to tackle the third wave of coronavirus.
Read More
Brazil approves proposal to import Bharat Biotech's Covaxin with regulatio
Updated : 5 years ago IST
Hyderabad [Telangana] , June 5 (ANI): Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday.
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 5 years ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More